Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152511 | 12615251 | 1 | I | 20160726 | 20160802 | 20160802 | EXP | JP-MYLANLABS-2016M1031543 | MYLAN | YAMASHINA T, TAKADA R, UEDO N, AKASAKA T, HANAOKA N, TAKEUCHI Y, ET AL. PROSPECTIVE SMALL BOWEL MUCOSAL ASSESSMENT IMMEDIATELY AFTER CHEMORADIOTHERAPY OF UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER USING CAPSULE ENDOSCOPY: A CASE SERIES. ANN-GASTROENTEROL 2016;29(3):386-388. | 0.00 | Y | 0.00000 | 20160802 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126152511 | 12615251 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 MG/M2; ON 1ST DAY OF RADIOTHERAPY THEREAFTER WEEKLY | U | U | 200145 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126152511 | 12615251 | 1 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126152511 | 12615251 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126152511 | 12615251 | Decreased appetite | |
| 126152511 | 12615251 | Duodenitis haemorrhagic | |
| 126152511 | 12615251 | Enteritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |